SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.

MLA

Wang, Zifeng, et al. “SETD7 Functions as a Transcription Repressor in Prostate Cancer via Methylating FOXA1.” Proceedings of the National Academy of Sciences of the United States of America, vol. 120, no. 33, Aug. 2023, p. e2220472120. EBSCOhost, https://doi.org/10.1073/pnas.2220472120.

APA

Wang, Z., Petricca, J., Liu, M., Zhang, S., Chen, S., Li, M., Besschetnova, A., Patalano, S., Venkataramani, K., Siegfried, K. R., Macoska, J. A., Han, D., Gao, S., Vedadi, M., Arrowsmith, C. H., He, H. H., & Cai, C. (2023). SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1. Proceedings of the National Academy of Sciences of the United States of America, 120(33), e2220472120. https://doi.org/10.1073/pnas.2220472120

Chicago

Wang, Zifeng, Jessica Petricca, Mingyu Liu, Songqi Zhang, Sujun Chen, Muqing Li, Anna Besschetnova, et al. 2023. “SETD7 Functions as a Transcription Repressor in Prostate Cancer via Methylating FOXA1.” Proceedings of the National Academy of Sciences of the United States of America 120 (33): e2220472120. doi:10.1073/pnas.2220472120.